PhD Monitor
/Detail
Gene Therapy and Rare Diseases● Open★ EU-FUNDED⏰ 0 days leftPreview

Predoctoral Researcher in Engineered AAV Vectors for Polycystic Kidney Disease Gene Therapy

Join the Renal Gene Therapy group to develop advanced AAV vectors for treating polycystic kidney disease through gene therapy.

Best for:Best for motivated predoctoral researchers with a background in biomedical sciences, gene therapy, or molecular biology seeking hands-on experience in translational research for rare diseases.

Fundación para la Investigación Médica Aplicada · Madrid, Spain · R1 · First-stage researcher
More professors at Fundación para la Investigación Médica Aplicada
adeno-associated virus (AAV) vectorspolycystic kidney disease (PKD)gene therapy for rare diseasestranslational biomedical researchvector engineering for disease adaptation
Deadline
Oct 14, 2026
0 days
Funding
Stipend
Unknown (funded by an EU programme)
Start date
flexible (expected to begin shortly after selection)
Full-time
Location
Madrid
Spain

Overview

This predoctoral researcher position is offered within the Renal Gene Therapy group, part of the Gene Therapy for Rare Diseases program at Fundación para la Investigación Médica Aplicada in Spain. The project focuses on engineering adeno-associated virus (AAV) vectors to adapt gene therapy treatments for polycystic kidney disease, addressing disease progression. The successful candidate will contribute to cutting-edge biomedical research, working under the supervision of Dr. Rafael Aldabe. The role involves hands-on laboratory work, experimental design, and collaboration within a multidisciplinary team. Applicants should have a strong background in biomedical sciences or related fields and a passion for translational research.

gene therapyAAV vectorspolycystic kidney diseaserare diseasesbiomedical researchtranslational medicinemolecular biologypreclinical research

What you'll do

  • Design and develop engineered AAV vectors for targeted gene therapy in polycystic kidney disease models.
  • Conduct in vitro and in vivo experiments to evaluate the efficacy and safety of AAV vector constructs.
  • Analyze and interpret experimental data to assess the therapeutic potential of gene therapy approaches.
  • Collaborate with multidisciplinary team members, including molecular biologists, geneticists, and clinicians.
  • Prepare scientific reports, presentations, and publications based on research findings.
  • Maintain detailed laboratory records and ensure compliance with ethical and regulatory standards.

Requirements

Degree required: Master’s degree in Biomedical Sciences, Molecular Biology, Genetics, or a related field.

Degree offered: PhD

Language: English; proficiency required for scientific communication and collaboration.

Instruction: English

Required skills
  • Hands-on experience in molecular cloning and recombinant DNA techniques.
  • Familiarity with AAV vector production and purification methods.
  • Experience with cell culture techniques and animal models for gene therapy studies.
  • Proficient in molecular biology laboratory techniques (PCR, gel electrophoresis, etc.).
  • Strong background in gene therapy or related biomedical research.
Nice to have
Experience with CRISPR/Cas9 or other gene-editing technologies.Familiarity with advanced imaging techniques for in vivo studies.Knowledge of bioinformatics tools for data analysis.Prior involvement in translational research projects.
Eligibility
  • Open to EU and non-EU candidates (check for specific visa/residency requirements).
  • No age restrictions, but typically suited for early-career researchers.
  • No prior experience caps, but relevant research experience is advantageous.

Funding & terms

Type
Stipend
Amount
Unknown (funded by an EU programme)
Duration
3 years (standard PhD duration)
Programme
Other EU programme
EU-FUNDEDEuropean Union (via an unspecified programme)

How to apply

Deadline: 2026-10-14 (Europe/Madrid)

Interested candidates should submit their application through the official Euraxess portal. The application must include a CV, a motivation letter, and academic transcripts. Additional documents may be requested depending on the evaluation process.

Documents required
  • Curriculum Vitae (CV)
  • Motivation letter
  • Academic transcripts (BSc and MSc)
  • Two letters of recommendation
↗Apply on site

Contact

Rafael Aldabe· Supervisor

RA
Prof.
Rafael Aldabe
Gene Therapy for Rare Diseases Program
Lab
Renal Gene Therapy Group
Fundación para la Investigación Médica Aplicada
Other EU programmeSpain
See the full position

Create a free profile to unlock your personal match score, the full requirements, funding details and how to apply — in English or Persian.

No card · 10 free AI match scores
Ready to apply?
0 days until the deadline — open this position on its website.